Colon Cancer Screening Toolkit for Colorectal Cancer

N/A

Recruiting

Led By Aimee James, Ph.D., MPH

Research Sponsored by Washington University School of Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up completion of follow-up (estimated to be 44 months)

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a multilevel intervention to improve follow-up rates for positive fecal immunochemical tests (FITs), which are used to screen for colorectal cancer (CRC). The intervention is being implemented in a rural, underserved area in Southern Illinois.

Who is the study for?

This trial is for people in rural Southern Illinois who have had a positive fecal immunochemical test (FIT) for colorectal cancer and need to follow up with a colonoscopy. It's focused on primary care clinic sites affiliated with the Southern Illinois Healthcare Physician Hospital Organization.

What is being tested?

The study is testing a 'Colorectal Cancer Toolkit' designed to improve follow-up rates after positive FIT results. The goal is to see if this toolkit helps more people get colonoscopies, which could lead to earlier detection of colorectal cancer in rural areas.

What are the potential side effects?

Since this trial involves an organizational intervention rather than medication, there are no direct side effects like you'd expect from drugs. However, participants may experience increased medical interactions or procedures as part of the enhanced follow-up process.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ completion of follow-up (estimated to be 44 months)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~completion of follow-up (estimated to be 44 months)

This trial's timeline: 3 weeks for screening, Varies for treatment, and completion of follow-up (estimated to be 44 months) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Number of colonoscopy completions after positive fecal immunochemical test

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Primary Care ClinicsExperimental Treatment1 Intervention

* Southern Illinois Healthcare System will contact the site management and ask for participation in the study * Eligible providers and staff will be identified by clinic management. The research coordinator will work with the clinic to schedule a virtual site visit(s). The study team will interview providers and staff at the beginning and/or end of each active intervention period to assess knowledge and attitudes about CRC screening and follow-up processes, the Consolidated Framework for Implementation Research (CFIR) constructs such as role clarity within the clinical team, and satisfaction with the intervention and implementation. Post-implementation surveys will also ask about work-arounds and adaptations of the intervention tools and perceived efficacy.

Do I qualify?Apply below to find out